Journal of Hepatology
Volume 53, Issue 4 , Pages 639-647, October 2010

Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury

  • Lars P. Bechmann

      Affiliations

    • Dept. of Gastroenterology and Hepatology, University Hospital, 45122 Essen, Germany
  • ,
  • Christoph Jochum

      Affiliations

    • Dept. of Gastroenterology and Hepatology, University Hospital, 45122 Essen, Germany
  • ,
  • Peri Kocabayoglu

      Affiliations

    • Dept. of Gastroenterology and Hepatology, University Hospital, 45122 Essen, Germany
    • Dept. of General and Transplantation Surgery, University Hospital, 45122 Essen, Germany
  • ,
  • Jan-Peter Sowa

      Affiliations

    • Dept. of Gastroenterology and Hepatology, University Hospital, 45122 Essen, Germany
  • ,
  • Marco Kassalik

      Affiliations

    • Dept. of Gastroenterology and Hepatology, University Hospital, 45122 Essen, Germany
  • ,
  • Robert K. Gieseler

      Affiliations

    • Dept. of Gastroenterology and Hepatology, University Hospital, 45122 Essen, Germany
    • Div. of R&D, Rodos BioTarget GmbH, Medical Park Hannover, 30625 Hannover, Germany
  • ,
  • Fuat Saner

      Affiliations

    • Dept. of General and Transplantation Surgery, University Hospital, 45122 Essen, Germany
  • ,
  • Andreas Paul

      Affiliations

    • Dept. of General and Transplantation Surgery, University Hospital, 45122 Essen, Germany
  • ,
  • Christian Trautwein

      Affiliations

    • Dept. of Gastroenterology and Hepatology, University Hospital, Aachen, Germany
  • ,
  • Guido Gerken

      Affiliations

    • Dept. of Gastroenterology and Hepatology, University Hospital, 45122 Essen, Germany
  • ,
  • Ali Canbay

      Affiliations

    • Dept. of Gastroenterology and Hepatology, University Hospital, 45122 Essen, Germany
    • Corresponding Author InformationCorresponding author. Address: Dept. of Gastroenterology and Hepatology, University Hospital, Hufelandstr. 55, 45122 Essen, Germany. Tel.: +49 (201) 723 84713; fax: +49 (201) 723 5719.

published online 01 July 2010.

Background & Aims

Predicting the probability of patients with acute liver failure (ALF) to recover spontaneously is of major clinical importance. As apoptotic and necrotic cell death are crucial in the pathogenesis of ALF, we determined whether selected cell-death markers predict outcome of patients with ALF and/or discriminate between etiologies.

Methods

In a prospective study (11/2006–06/2009), 68 ALF patients were recruited consecutively. Data were collected over four weeks or until discharge, death or LTx, including CK18/M65 and M30 ELISA and glutathione S-transferase, subtype α. Data at date of admission and at the date of peak levels of M65 were individually analyzed and correlated with the patients’ prognosis and etiology.

Results

The predictive sensitivity of total serum M65 for lethal outcome was comparable to the Model for End-Stage Liver Disease (MELD) score at time of admission and at its peak value. In contrast, serum bilirubin levels had no prognostic value, neither at admission nor at later time points. In order to accurately predict the clinical prognosis of ALF patients, we tested a modified MELD score where CK18 M65 substituted bilirubin. This CK18/M65-based MELD score significantly better predicted the prognosis of ALF patients compared with the current MELD score or KCC. A combination of tested parameters contributed to improved discrimination of ALF etiologies by applying cell death and established laboratory parameters.

Conclusions

The CK18 M65-based MELD score has superior sensitivity and specifically predicts survival of ALF patients. Further prospective clinical studies could validate its potential role to predict requirement of LTx in ALF patients.

Abbreviations: ALF, acute liver failure, LTx, liver transplantation, CK18, cytokeratin 18, KCC, Kings College Criteria, MELD, Model for End-Stage Liver Disease, ELISA, enzyme-linked immunosorbent assay, GST-α, glutathione S-transferase, subtype α, CHF, congestive heart failure, ALI, acute liver injury, SR, spontaneous remission, NSR, non-spontaneous remission, AST, aspartate aminotransferase, ALT, alanine aminotransferase, AP, alcalic phosphatase, γ-GT, gamma-glutathione, INR, international normalized ratio, AUC, area under the curve, M-MELD, M65 modified Model for End-Stage Liver Disease, AAP, acetaminophene poisoning, NAAP, non-acetaminophen poisoning, GLDH, glutamate dehydrogenase, HBV, hepatitis B virus

Keywords: Apoptosis, Cell death, Acute liver failure

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8278(10)00554-4

doi:10.1016/j.jhep.2010.04.029

Refers to article:

  • Prognosis indicator in acute liver failure: Is there a place for cell death markers? , 29 June 2010

    Didier Samuel, Philippe Ichai
    Journal of Hepatology October 2010 (Vol. 53, Issue 4, Pages 593-595)

Journal of Hepatology
Volume 53, Issue 4 , Pages 639-647, October 2010